Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
NVCT · NASDAQ · Pharmaceutical Preparations
$19.84−0.45 (−2.22%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day
Nuvectis Pharma (NVCT) · oqro.io/stocks/NVCT · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Fund moves · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Perceptive Advisors LLC disclosed a new position in NVCT for Q2 2026SourceInsider trade · Traded Jun 20, 2025 · Filed Jun 24, 2025
10% owner purchased ~$45K of NVCT shares in the open marketSourceInsider trade · Traded Jun 18, 2025 · Filed Jun 20, 2025
10% owner purchased ~$226K of NVCT shares in the open marketSourceInsider trade · Traded Jun 17, 2025 · Filed Jun 20, 2025
10% owner purchased ~$44K of NVCT shares in the open marketSourceInsider trade · Traded May 12, 2025 · Filed May 13, 2025
10% owner purchased ~$172K of NVCT shares in the open marketSourceInsider trade · Traded May 9, 2025 · Filed May 12, 2025
10% owner purchased ~$88K of NVCT shares in the open marketSourceInsider trade · Traded May 9, 2025 · Filed May 12, 2025
10% owner purchased ~$87K of NVCT shares in the open marketSourceInsider trade · Traded May 9, 2025 · Filed May 12, 2025
10% owner purchased ~$48K of NVCT shares in the open marketSourceInsider trade · Traded Feb 7, 2025 · Filed Feb 11, 2025
10% owner purchased ~$1.2M of NVCT shares in the open marketSourceInsider trade · Traded Dec 24, 2024 · Filed Dec 26, 2024
CEO purchased ~$21K of NVCT shares in the open marketSourceInsider trade · Traded Dec 12, 2024 · Filed Dec 16, 2024
10% owner purchased ~$149K of NVCT shares in the open marketSourceInsider trade · Traded Dec 13, 2024 · Filed Dec 16, 2024
10% owner purchased ~$80K of NVCT shares in the open marketSourceInsider trade · Traded Nov 19, 2024 · Filed Nov 20, 2024
Officer purchased ~$10K of NVCT shares in the open marketSourceInsider trade · Traded Nov 15, 2024 · Filed Nov 18, 2024
CEO purchased ~$98K of NVCT shares in the open marketSourceInsider trade · Traded Nov 7, 2024 · Filed Nov 8, 2024
Officer sold ~$22K of NVCT shares in the open marketSourceInsider trade · Traded May 8, 2025 · Filed May 12, 2025
10% owner purchased ~$22K of NVCT shares in the open marketSourceInsider trade · Traded May 8, 2025 · Filed May 12, 2025
10% owner purchased ~$899 of NVCT shares in the open marketSourceInsider trade · Traded May 8, 2025 · Filed May 12, 2025
10% owner purchased ~$871 of NVCT shares in the open marketSource